Whitehead Institute for Biomedical Research, Cambridge, MA 02142, USA.
Whitehead Institute for Biomedical Research, Cambridge, MA 02142, USA; Fulcrum Therapeutics, One Kendall Square, Binney Street b7102, Cambridge, MA 02139, USA.
Cell. 2018 Feb 22;172(5):979-992.e6. doi: 10.1016/j.cell.2018.01.012. Epub 2018 Feb 15.
Fragile X syndrome (FXS), the most common genetic form of intellectual disability in males, is caused by silencing of the FMR1 gene associated with hypermethylation of the CGG expansion mutation in the 5' UTR of FMR1 in FXS patients. Here, we applied recently developed DNA methylation editing tools to reverse this hypermethylation event. Targeted demethylation of the CGG expansion by dCas9-Tet1/single guide RNA (sgRNA) switched the heterochromatin status of the upstream FMR1 promoter to an active chromatin state, restoring a persistent expression of FMR1 in FXS iPSCs. Neurons derived from methylation-edited FXS iPSCs rescued the electrophysiological abnormalities and restored a wild-type phenotype upon the mutant neurons. FMR1 expression in edited neurons was maintained in vivo after engrafting into the mouse brain. Finally, demethylation of the CGG repeats in post-mitotic FXS neurons also reactivated FMR1. Our data establish that demethylation of the CGG expansion is sufficient for FMR1 reactivation, suggesting potential therapeutic strategies for FXS.
脆性 X 综合征(FXS)是男性中最常见的遗传性智力障碍,由与 FMR1 基因沉默相关的 CGG 扩展突变的超甲基化引起,该突变位于 FMR1 的 5'UTR 中。在这里,我们应用了最近开发的 DNA 甲基化编辑工具来逆转这种超甲基化事件。dCas9-Tet1/单指导 RNA(sgRNA)靶向 CGG 扩展的去甲基化将上游 FMR1 启动子的异染色质状态转变为活性染色质状态,恢复 FXS iPSC 中 FMR1 的持续表达。源自甲基化编辑的 FXS iPSC 的神经元挽救了电生理异常,并在突变神经元上恢复了野生型表型。编辑后的神经元在植入小鼠大脑后,其 FMR1 表达在体内得以维持。最后,有丝分裂后 FXS 神经元中的 CGG 重复序列的去甲基化也能重新激活 FMR1。我们的数据表明,CGG 扩展的去甲基化足以激活 FMR1,这为 FXS 提供了潜在的治疗策略。